-
1
-
-
33646524699
-
Peroxisome proliferator-activated receptors and inflammation
-
Moraes LA, Piqueras L, Bishop-Bailey D. Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther. 2006;110:371-385.
-
(2006)
Pharmacol Ther
, vol.110
, pp. 371-385
-
-
Moraes, L.A.1
Piqueras, L.2
Bishop-Bailey, D.3
-
2
-
-
0037389926
-
Peroxisome proliferator-activated receptors: A critical review on endogenous pathways for ligand generation
-
Bishop-Bailey D, Wray J. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation. Prostaglandins Other Lipid Mediat. 2003;71:1-22.
-
(2003)
Prostaglandins Other Lipid Mediat
, vol.71
, pp. 1-22
-
-
Bishop-Bailey, D.1
Wray, J.2
-
3
-
-
0028321529
-
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
-
Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A. 1994;91:7355-7359.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, pp. 7355-7359
-
-
Kliewer, S.A.1
Forman, B.M.2
Blumberg, B.3
Ong, E.S.4
Borgmeyer, U.5
Mangelsdorf, D.J.6
Umesono, K.7
Evans, R.M.8
-
4
-
-
0037039374
-
Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer
-
Barak Y, Liao D, He W, Ong ES, Nelson MC, Olefsky JM, Boland R, Evans RM. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A. 2002;99:303-308.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 303-308
-
-
Barak, Y.1
Liao, D.2
He, W.3
Ong, E.S.4
Nelson, M.C.5
Olefsky, J.M.6
Boland, R.7
Evans, R.M.8
-
5
-
-
0035921419
-
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice
-
Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, Rieusset J, Peters JM, Kaya G, Gonzalez FJ, Zakany J, Metzger D, Chambon P, Duboule D, Wahli W. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol. 2001;154:799-814.
-
(2001)
J Cell Biol
, vol.154
, pp. 799-814
-
-
Michalik, L.1
Desvergne, B.2
Tan, N.S.3
Basu-Modak, S.4
Escher, P.5
Rieusset, J.6
Peters, J.M.7
Kaya, G.8
Gonzalez, F.J.9
Zakany, J.10
Metzger, D.11
Chambon, P.12
Duboule, D.13
Wahli, W.14
-
6
-
-
33751533892
-
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
-
Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev. 2006;58:726-741.
-
(2006)
Pharmacol Rev
, vol.58
, pp. 726-741
-
-
Michalik, L.1
Auwerx, J.2
Berger, J.P.3
Chatterjee, V.K.4
Glass, C.K.5
Gonzalez, F.J.6
Grimaldi, P.A.7
Kadowaki, T.8
Lazar, M.A.9
O'Rahilly, S.10
Palmer, C.N.11
Plutzky, J.12
Reddy, J.K.13
Spiegelman, B.M.14
Staels, B.15
Wahli, W.16
-
7
-
-
43249129514
-
Activation of PPARδ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress and increases fatty acid oxidation in moderately obese men
-
In press
-
Risérus U, Sprecher D, Johnson T, Olson E, Hirschberg S, Liu A, Fang Z, Hegde P, Richards D, Sarov-Blat L, Strum JC, Basu S, Cheeseman J, Fielding BA, Humphreys SM, Danoff T, Moore NR, Murgatroyd P, O'Rahilly S, Sutton P, Willson T, Hassall D, Frayn KN, Karpe F. Activation of PPARδ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress and increases fatty acid oxidation in moderately obese men. Diabetes. In press.
-
Diabetes
-
-
Risérus, U.1
Sprecher, D.2
Johnson, T.3
Olson, E.4
Hirschberg, S.5
Liu, A.6
Fang, Z.7
Hegde, P.8
Richards, D.9
Sarov-Blat, L.10
Strum, J.C.11
Basu, S.12
Cheeseman, J.13
Fielding, B.A.14
Humphreys, S.M.15
Danoff, T.16
Moore, N.R.17
Murgatroyd, P.18
O'Rahilly, S.19
Sutton, P.20
Willson, T.21
Hassall, D.22
Frayn, K.N.23
Karpe, F.24
more..
-
8
-
-
33644645013
-
PPAR delta: A dagger in the heart of the metabolic syndrome
-
Barish GD, Narkar VA, Evans RM. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest. 2006;116:590-597.
-
(2006)
J Clin Invest
, vol.116
, pp. 590-597
-
-
Barish, G.D.1
Narkar, V.A.2
Evans, R.M.3
-
9
-
-
20444378931
-
The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice
-
Graham TL, Mookherjee C, Suckling KE, Palmer CN, Patel L. The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice. Atherosclerosis. 2005;181:29-37.
-
(2005)
Atherosclerosis
, vol.181
, pp. 29-37
-
-
Graham, T.L.1
Mookherjee, C.2
Suckling, K.E.3
Palmer, C.N.4
Patel, L.5
-
10
-
-
85047693466
-
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma
-
Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, Valledor AF, Davis RA, Willson TM, Witztum JL, Palinski W, Glass CK. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest. 2004;114:1564-1576.
-
(2004)
J Clin Invest
, vol.114
, pp. 1564-1576
-
-
Li, A.C.1
Binder, C.J.2
Gutierrez, A.3
Brown, K.K.4
Plotkin, C.R.5
Pattison, J.W.6
Valledor, A.F.7
Davis, R.A.8
Willson, T.M.9
Witztum, J.L.10
Palinski, W.11
Glass, C.K.12
-
11
-
-
0142116239
-
Transcriptional repression of atherogenic inflammation: Modulation by PPARdelta
-
Lee CH, Chawla A, Urbiztondo N, Liao D, Boisvert WA, Curtiss LK, Evans RM. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science. 2003;302:453-457.
-
(2003)
Science
, vol.302
, pp. 453-457
-
-
Lee, C.H.1
Chawla, A.2
Urbiztondo, N.3
Liao, D.4
Boisvert, W.A.5
Curtiss, L.K.6
Evans, R.M.7
-
12
-
-
0037168869
-
PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells
-
Rival Y, Beneteau N, Taillandier T, Pezet M, Dupont-Passelaigue E, Patoiseau JF, Junquero D, Colpaert FC, Delhon A. PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells. Eur J Pharmacol. 2002;435:143-151.
-
(2002)
Eur J Pharmacol
, vol.435
, pp. 143-151
-
-
Rival, Y.1
Beneteau, N.2
Taillandier, T.3
Pezet, M.4
Dupont-Passelaigue, E.5
Patoiseau, J.F.6
Junquero, D.7
Colpaert, F.C.8
Delhon, A.9
-
13
-
-
38549127422
-
Suppression of proinflammatory adhesion molecules by PPAR-δ in human vascular endothelial cells
-
In press
-
Fan Y, Wang Y, Tang Z, Zhang H, Qin X, Zhu Y, Guan Y, Wang X, Staels B, Chien S, Wang N. Suppression of proinflammatory adhesion molecules by PPAR-δ in human vascular endothelial cells. Arterioscler Thromb Vasc Biol. In press.
-
Arterioscler Thromb Vasc Biol
-
-
Fan, Y.1
Wang, Y.2
Tang, Z.3
Zhang, H.4
Qin, X.5
Zhu, Y.6
Guan, Y.7
Wang, X.8
Staels, B.9
Chien, S.10
Wang, N.11
-
14
-
-
33846577833
-
Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis
-
Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T, Tanabe T, Warner TD, Bishop-Bailey D. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol. 2007;27:63-69.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 63-69
-
-
Piqueras, L.1
Reynolds, A.R.2
Hodivala-Dilke, K.M.3
Alfranca, A.4
Redondo, J.M.5
Hatae, T.6
Tanabe, T.7
Warner, T.D.8
Bishop-Bailey, D.9
-
15
-
-
34547791776
-
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice
-
Muller-Brusselbach S, Komhoff M, Rieck M, Meissner W, Kaddatz K, Adamkiewicz J, Keil B, Klose KJ, Moll R, Burdick AD, Peters JM, Muller R. Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice. EMBO J. 2007;26:3686-3698.
-
(2007)
EMBO J
, vol.26
, pp. 3686-3698
-
-
Muller-Brusselbach, S.1
Komhoff, M.2
Rieck, M.3
Meissner, W.4
Kaddatz, K.5
Adamkiewicz, J.6
Keil, B.7
Klose, K.J.8
Moll, R.9
Burdick, A.D.10
Peters, J.M.11
Muller, R.12
-
16
-
-
34547891037
-
Transcriptional network governing the angiogenic switch in human pancreatic cancer
-
Abdollahi A, Schwager C, Kleeff J, Esposito I, Domhan S, Peschke P, Hauser K, Hahnfeldt P, Hlatky L, Debus J, Peters JM, Friess H, Folkman J, Huber PE. Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A. 2007;104:12890-12895.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 12890-12895
-
-
Abdollahi, A.1
Schwager, C.2
Kleeff, J.3
Esposito, I.4
Domhan, S.5
Peschke, P.6
Hauser, K.7
Hahnfeldt, P.8
Hlatky, L.9
Debus, J.10
Peters, J.M.11
Friess, H.12
Folkman, J.13
Huber, P.E.14
-
17
-
-
41149134486
-
Transforming growth factor-β1 is a molecular target for the peroxisome proliferator-activated receptor δ
-
Kim HJ, Ham SA, Kim SU, Hwang JY, Kim JH, Chang KC, Yabe-Nishimura C, Kim JH, Seo HG. Transforming growth factor-β1 is a molecular target for the peroxisome proliferator-activated receptor δ. Circ Res. 2008;102:193-200.
-
(2008)
Circ Res
, vol.102
, pp. 193-200
-
-
Kim, H.J.1
Ham, S.A.2
Kim, S.U.3
Hwang, J.Y.4
Kim, J.H.5
Chang, K.C.6
Yabe-Nishimura, C.7
Kim, J.H.8
Seo, H.G.9
-
18
-
-
34047156083
-
TGF-beta and atherosclerosis in man
-
Grainger DJ. TGF-beta and atherosclerosis in man. Cardiovasc Res. 2007;74:213-222.
-
(2007)
Cardiovasc Res
, vol.74
, pp. 213-222
-
-
Grainger, D.J.1
-
19
-
-
0035834818
-
Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice
-
Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamaté C, Merval R, Fradelizi D, Tedgui A. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res. 2001;89:930-934.
-
(2001)
Circ Res
, vol.89
, pp. 930-934
-
-
Mallat, Z.1
Gojova, A.2
Marchiol-Fournigault, C.3
Esposito, B.4
Kamaté, C.5
Merval, R.6
Fradelizi, D.7
Tedgui, A.8
-
20
-
-
0036078307
-
Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression
-
Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE, Daemen MJ. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol. 2002;22:975-982.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 975-982
-
-
Lutgens, E.1
Gijbels, M.2
Smook, M.3
Heeringa, P.4
Gotwals, P.5
Koteliansky, V.E.6
Daemen, M.J.7
|